Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7469 p282
15 September 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Scottish Executive funds pharmacy methadone study

Duncan Walker/iStockphoto

Drug misusers

Drug misusers' outlook could improve

Pharmacists in Scotland are to take part in a new research project to help improve outcomes for methadone patients. The study has attracted £184,000 of funding from the Scottish Executive over two years.

Pharmacists from 74 pharmacies across the country will be randomised either to take part in motivational interviewing training or to continue with their usual practice. Over 700 drug misuse patients will be involved.

Catriona Matheson, from the department of general practice and primary care at the University of Aberdeen, is leading the research. She told The Journal that the five health boards taking part would provide the university with the details of pharmacists offering methadone services to high numbers of drug misuse patients, and these pharmacists would be invited to participate in the study.

Preparation for the project will start next month, and pharmacists will begin to recruit patients in the new year. Pharmacists in the intervention group will undergo two initial training sessions on motivational interviewing, targeted around the pharmacy setting, with two further sessions taking place at monthly intervals.

“Motivational interviewing as a counselling technique is increasingly used with addictions,” Dr Matheson explained. “We aim to see if this training can improve the way we deliver methadone maintenance therapy, and improve treatment outcomes for patients.”

She hopes that the intervention will help drug misusers to identify their own goals and think about their behaviour, and to overcome ambivalence towards treatment.

“This is a very exciting opportunity for pharmacists to demonstrate to the wider community what an important impact they have in drug misuse services,” Dr Matheson said.

“This is a controversial area that is often shunned by other generalist health providers but pharmacists have risen to the challenge of managing those with drug misuse problems without prejudice. Even to receive funding for a project in this field is an achievement as drug-related research is very underfunded. We are looking forward to working with pharmacists and developing the scientific evidence in this area, as well as enabling those with drug problems to receive optimal care.”

Misuse of medicines The need to reinforce the role of community pharmacy in ensuring medicines are used appropriately has been highlighted by wholesaler AAH Pharmaceuticals in its response to an All-Party Group on Drug Misuse inquiry into drugs misuse.

AAH group managing director Steve Dunn said: “In our submission, we have highlighted the role of community pharmacy in providing a nationwide network of community pharmacies which patients can access easily. Clearly, the opportunity to abuse or misuse medicines is far less when access is via a professional, regulated network, such as pharmacy.”

Back to Top


©The Pharmaceutical Journal